Growth Metrics

Bionano Genomics (BNGO) Short-Term Debt repayments (2019 - 2020)

Bionano Genomics recorded quarterly Short-Term Debt repayments of $102000.0 in Q2 2020, down 95.27% quarter-over-quarter from $2.2 million in Q1 2020, and down 66.67% year-over-year from $306000.0 in Q3 2019.

Bionano Genomics' Short-Term Debt repayments history runs 2 years deep, the most recent figure standing at $102000.0 for Q2 2020.

  • In Q2 2020, Short-Term Debt repayments fell 66.67% year-over-year to $102000.0; the TTM figure through Mar 2021 stood at $102000.0 (down 98.23% YoY), while the FY2020 annual figure was $2.3 million, down 37.54% from the prior year.
  • Short-Term Debt repayments came in at $102000.0 for Q2 2020 at Bionano Genomics, down from $2.2 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $2.2 million in Q1 2020 to a low of $102000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Bionano Genomics 14.92 Mn 539,417.67 3.25 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 102,000.00
Jun 30, 2020 102,000.00
Mar 31, 2020 2.16 Mn
Mar 31, 2020 2.16 Mn
Dec 31, 2019 1.48 Mn
Dec 31, 2019 1.48 Mn
Sep 30, 2019 1.83 Mn
Sep 30, 2019 1.83 Mn
Jun 30, 2019 306,000.00
Jun 30, 2019 306,000.00